Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible

DOI QR Code

Ashoor A, Shephard J, Lissidini G, Nicosia L. Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean J Radiol 2021;22:2124-2126 https://doi.org/10.3348/kjr.2021.0635
Weeks JK, O'Brien SR, Rosenspire KC, Dubroff JG, Pantel AR. Evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clin Nucl Med 2021;46:1011-1012 https://doi.org/10.1097/RLU.0000000000003711
Hagen C, Nowack M, Messerli M, Saro F, Mangold F, Bode PK. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Swiss Med Wkly 2021;151:w20557
El-Sayed MS, Wechie GN, Low CS, Adesanya O, Rao N, Leung VJ. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT. Clin Med (Lond) 2021;21:e633-e638 https://doi.org/10.7861/clinmed.2021-0420
Baek DW, Hwang S, Kim J, Lee JM, Cho HJ, Moon JH, et al. Patients presenting high fever with lymphadenopathy after COVID-19 vaccination were diagnosed with hemophagocytic lymphohistiocytosis. Infect Dis (Lond) 2022;54:303-307 https://doi.org/10.1080/23744235.2021.2010801
Lane DL, Neelapu SS, Xu G, Weaver O. COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean J Radiol 2021;22:1938-1945 https://doi.org/10.3348/kjr.2021.0350